Hubei Guangji Pharmaceutical Co Ltd (000952) — Financial Flexibility Index
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥31.05 Million (operating CF CN¥22.38 Million minus capex CN¥8.67 Million) represents 0% of total liabilities (CN¥1.62 Billion). Check total reinvestment intensity of Hubei Guangji Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hubei Guangji Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Hubei Guangji Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see 000952 cash flow conversion.
Annual Financial Flexibility Index for Hubei Guangji Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Hubei Guangji Pharmaceutical Co Ltd. Explore Hubei Guangji Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥96.07 Million | CN¥60.43 Million | CN¥1.69 Billion | ▼ -37.1% |
| 2024 | 0.09x | CN¥155.59 Million | CN¥655.36K | CN¥1.72 Billion | ▼ -64.4% |
| 2023 | 0.25x | CN¥417.17 Million | CN¥-148.96 Million | CN¥1.64 Billion | ▲ +0.1% |
| 2022 | 0.25x | CN¥248.79 Million | CN¥45.08 Million | CN¥977.25 Million | ▼ -11.7% |
| 2021 | 0.29x | CN¥172.51 Million | CN¥75.91 Million | CN¥598.09 Million | ▼ -18.5% |
| 2020 | 0.35x | CN¥217.27 Million | CN¥119.38 Million | CN¥613.75 Million | ▲ +7.6% |
| 2019 | 0.33x | CN¥263.96 Million | CN¥144.20 Million | CN¥802.21 Million | ▼ -13.2% |
| 2018 | 0.38x | CN¥307.97 Million | CN¥231.44 Million | CN¥812.33 Million | ▲ +28.0% |
| 2017 | 0.30x | CN¥259.74 Million | CN¥178.83 Million | CN¥876.65 Million | ▲ +3.1% |
| 2016 | 0.29x | CN¥280.02 Million | CN¥167.07 Million | CN¥974.70 Million | ▲ +315.2% |
| 2015 | 0.07x | CN¥76.59 Million | CN¥-33.35 Million | CN¥1.11 Billion | ▲ +273.8% |
| 2014 | 0.02x | CN¥19.94 Million | CN¥-74.69 Million | CN¥1.08 Billion | ▼ -89.6% |
| 2013 | 0.18x | CN¥145.20 Million | CN¥95.16 Million | CN¥816.78 Million | ▼ -37.2% |
| 2012 | 0.28x | CN¥225.48 Million | CN¥108.02 Million | CN¥795.93 Million | ▼ -35.6% |
| 2011 | 0.44x | CN¥282.84 Million | CN¥81.88 Million | CN¥643.07 Million | ▲ +24.4% |
| 2010 | 0.35x | CN¥192.74 Million | CN¥77.18 Million | CN¥545.06 Million | ▲ +37.1% |
| 2009 | 0.26x | CN¥125.58 Million | CN¥-24.35 Million | CN¥486.93 Million | ▼ -76.8% |
| 2008 | 1.11x | CN¥440.46 Million | CN¥220.70 Million | CN¥395.78 Million | ▼ -4.8% |
| 2007 | 1.17x | CN¥380.92 Million | CN¥331.98 Million | CN¥325.76 Million | ▲ +148.4% |
| 2006 | 0.47x | CN¥144.68 Million | CN¥125.95 Million | CN¥307.34 Million | ▲ +106.4% |
| 2005 | 0.23x | CN¥79.98 Million | CN¥54.14 Million | CN¥350.68 Million | ▲ +100.3% |
| 2004 | 0.11x | CN¥44.27 Million | CN¥-3.32 Million | CN¥388.76 Million | ▼ -20.3% |
| 2003 | 0.14x | CN¥50.34 Million | CN¥-15.40 Million | CN¥352.38 Million | ▼ -64.7% |
| 2002 | 0.40x | CN¥126.72 Million | CN¥76.20 Million | CN¥313.05 Million | ▲ +355.4% |
| 2001 | 0.09x | CN¥24.44 Million | CN¥-22.40 Million | CN¥274.96 Million | ▼ -76.5% |
| 2000 | 0.38x | CN¥73.67 Million | CN¥48.57 Million | CN¥194.67 Million | ▼ -63.0% |
| 1999 | 1.02x | CN¥204.15 Million | CN¥68.57 Million | CN¥199.49 Million | ▲ +1650.4% |
| 1998 | -0.07x | CN¥-12.33 Million | CN¥-15.29 Million | CN¥186.80 Million | — |